These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4363967)

  • 1. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.
    Sugita M; Iwamori M; Evans J; McCluer RH; Dulaney JT; Moser HW
    J Lipid Res; 1974 May; 15(3):223-6. PubMed ID: 4363967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.
    Sugita M; Connolly P; Dulaney JT; Moser HW
    Lipids; 1973 Jul; 8(7):401-6. PubMed ID: 4740649
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.
    Sugita M; Willians M; Dulaney JT; Moser HW
    Biochim Biophys Acta; 1975 Jul; 398(1):125-31. PubMed ID: 238641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.
    Toppet M; Vamos-Hurwitz E; Jonniaux G; Cremer N; Tondeur M; Pelc S
    Acta Paediatr Scand; 1978 Jan; 67(1):113-9. PubMed ID: 626064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.
    Iwamori M; Moser HW
    Clin Chem; 1975 May; 21(6):725-9. PubMed ID: 1122616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.
    Samuelsson K; Zetterström R
    Scand J Clin Lab Invest; 1971 Jun; 27(4):393-405. PubMed ID: 5109101
    [No Abstract]   [Full Text] [Related]  

  • 7. [Farber's disease (disseminated lipogranulomatosis) (author's transl)].
    Schönenberg H; Lindenfelser R
    Monatsschr Kinderheilkd (1902); 1974 Apr; 122(4):153-9. PubMed ID: 4832028
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography.
    Iwamori M; Costello C; Moser HW
    J Lipid Res; 1979 Jan; 20(1):86-96. PubMed ID: 438657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Farber's disease. Anatomoclinical and ultrastructural study].
    Dustin P; Tondeur M; Jonniaux G; Vamos-Hurwitz E; Pelc S
    Bull Acad R Med Belg; 1974 Oct; 13(9):733-62. PubMed ID: 4479365
    [No Abstract]   [Full Text] [Related]  

  • 10. The cellular lesions of Farber's disease and their experimental reproduction in tissue culture.
    Rutsaert J; Tondeur M; Vamos-Hurwitz E; Dustin P
    Lab Invest; 1977 May; 36(5):474-80. PubMed ID: 194109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
    Sugita M; Dulaney JT; Moser HW
    Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside.
    Moser HW; Prensky AL; Wolfe HJ; Rosman NP
    Am J Med; 1969 Dec; 47(6):869-90. PubMed ID: 5395479
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial lipogranulomatosis (Farber's disease).
    Amirhakimi GH; Haghighi P; Ghalambor MA; Honari S
    Clin Genet; 1976 Jun; 9(6):625-30. PubMed ID: 1277575
    [No Abstract]   [Full Text] [Related]  

  • 14. The biochemical defect in Farber's disease.
    Dulaney J; Moser HW; Sidbury J; Milunsky A
    Adv Exp Med Biol; 1976; 68():403-11. PubMed ID: 937114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ultrastructural aspects of peripheral nerve lesions in one case of Farber's disease].
    Vital C; Battin J; Rivel J; Hehunstre JP
    Rev Neurol (Paris); 1976 Jun; 132(6):419-23. PubMed ID: 181809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical studies of Farber's disease.
    Clausen J; Rampini S
    Acta Neurol Scand; 1970; 46(3):313-22. PubMed ID: 5535909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indicative radiologic features in disseminated lipogranulomatosis (Farber's disease)].
    Dihlmann W
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Jul; 117(1):47-51. PubMed ID: 4341608
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
    Chen WW; Decker GL
    Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Ketosphingolipids: application to the determination of sphingolipids which contain 4-sphingenine.
    Iwamori M; Moser HW; McCluer RH; Kishimoto Y
    Biochim Biophys Acta; 1975 Feb; 380(2):308-19. PubMed ID: 1120148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farber's disease (disseminated lipogranulomatosis)--a pathological, histochemical and ultrastructural study--.
    Tanaka T; Takahashi K; Hakozaki H; Kimoto H; Suzuki Y
    Acta Pathol Jpn; 1979 Jan; 29(1):135-55. PubMed ID: 219658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.